(Q44408004)
Statements
1 reference
TRIZAL study: switching from successful HAART to Trizivir (abacavir-lamivudine-zidovudine combination tablet): 48 weeks efficacy, safety and adherence results (English)
1 reference
C Katlama
1 reference
S Fenske
1 reference
B Gazzard
1 reference
A Lazzarin
1 reference
N Clumeck
1 reference
J Mallolas
1 reference
A Lafeuillade
1 reference
J-P Mamet
1 reference
L Beauvais
1 reference
AZL30002 European study team
1 reference
1 April 2003
1 reference
1 reference
4
1 reference
2
1 reference
79-86
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference